Achillion Shares Spike Higher, Near $11 As UBS Analyst Sees Possibility Of M&A

By: via Benzinga
Shares of Achillion Pharma (NASDAQ: ACHN) got a mid-day pop Monday following some bullish comments from UBS's Andrew Peters. The stock ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.